USANA Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essen… Read more
Market Cap & Net Worth: USANA Health Sciences Inc (USNA)
USANA Health Sciences Inc (NYSE:USNA) has a market capitalization of $322.84 Million ($322.84 Million) as of March 19, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #15859 globally and #6174 in its home market, demonstrating a 0.06% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying USANA Health Sciences Inc's stock price $17.66 by its total outstanding shares 18280857 (18.28 Million).
USANA Health Sciences Inc Market Cap History: 2015 to 2026
USANA Health Sciences Inc's market capitalization history from 2015 to 2026. Data shows change from $1.17 Billion to $312.42 Million (-11.43% CAGR).
Index Memberships
USANA Health Sciences Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Small-Cap 600 Index
SML
|
$1.36 Trillion | 0.02% | #559 of 602 |
Weight: USANA Health Sciences Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
USANA Health Sciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how USANA Health Sciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.77x
USANA Health Sciences Inc's market cap is 0.77 times its annual revenue
0.14x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
15.61x
USANA Health Sciences Inc's market cap is 15.61 times its annual earnings
5.50x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.17 Billion | $918.50 Million | $94.67 Million | 1.27x | 12.33x |
| 2016 | $1.12 Billion | $1.01 Billion | $100.04 Million | 1.11x | 11.18x |
| 2017 | $1.35 Billion | $1.05 Billion | $62.53 Million | 1.29x | 21.65x |
| 2018 | $2.15 Billion | $1.19 Billion | $126.22 Million | 1.81x | 17.05x |
| 2019 | $1.44 Billion | $1.06 Billion | $100.53 Million | 1.35x | 14.28x |
| 2020 | $1.41 Billion | $1.13 Billion | $124.66 Million | 1.24x | 11.31x |
| 2021 | $1.85 Billion | $1.19 Billion | $116.50 Million | 1.56x | 15.88x |
| 2022 | $972.54 Million | $998.60 Million | $69.35 Million | 0.97x | 14.02x |
| 2023 | $979.85 Million | $921.01 Million | $63.79 Million | 1.06x | 15.36x |
| 2024 | $656.10 Million | $854.50 Million | $42.03 Million | 0.77x | 15.61x |
Competitor Companies of USNA by Market Capitalization
Companies near USANA Health Sciences Inc in the global market cap rankings as of March 19, 2026.
Key companies related to USANA Health Sciences Inc by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #55 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #68 globally with a market cap of $226.90 Billion USD ( CHF207.77 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #437 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #458 globally with a market cap of $47.46 Billion USD ( €46.23 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #55 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #68 | Nestlé S.A. | SW:NESN | $226.90 Billion | CHF80.84 |
| #437 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #458 | Danone SA | PA:BN | $47.46 Billion | €73.12 |
USANA Health Sciences Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, USANA Health Sciences Inc's market cap moved from $1.17 Billion to $ 312.42 Million, with a yearly change of -11.43%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $312.42 Million | -12.94% |
| 2025 | $358.85 Million | -45.31% |
| 2024 | $656.10 Million | -33.04% |
| 2023 | $979.85 Million | +0.75% |
| 2022 | $972.54 Million | -47.43% |
| 2021 | $1.85 Billion | +31.26% |
| 2020 | $1.41 Billion | -1.85% |
| 2019 | $1.44 Billion | -33.28% |
| 2018 | $2.15 Billion | +58.99% |
| 2017 | $1.35 Billion | +21.00% |
| 2016 | $1.12 Billion | -4.19% |
| 2015 | $1.17 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of USANA Health Sciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $322.84 Million USD |
| MoneyControl | $322.84 Million USD |
| MarketWatch | $322.84 Million USD |
| marketcap.company | $322.84 Million USD |
| Reuters | $322.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.